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Abstract
Background: X-tox proteins are a family of immune-related proteins only found in Lepidoptera and characterized by
imperfectly conserved tandem repeats of several defensin-like motifs. Previous phylogenetic analysis of X-tox genes
supported the hypothesis that X-tox have evolved from defensins in a lineage-specific gene evolution restricted to
Lepidoptera. In this paper, we performed a protein study in which we asked whether X-tox proteins have conserved the
antimicrobial functions of their ancestral defensins and have evolved as defensin reservoirs.
Methodology/Principal Findings: We followed the outcome of Spod-11-tox, an X-tox protein characterized in Spodoptera
frugiperda, in bacteria-challenged larvae using both immunochemistry and antimicrobial assays. Three hours post infection,
the Spod-11-tox protein was expressed in 80% of the two main classes of circulating hemocytes (granulocytes and
plasmatocytes). Located in secretory granules of hemocytes, Spod-11-tox was never observed in contact with
microorganisms entrapped within phagolyzosomes showing that Spod-11-tox is not involved in intracellular pathogen
killing. In fact, the Spod-11-tox protein was found to be secreted into the hemolymph of experimentally challenged larvae.
In order to determine antimicrobial properties of the Spod-11-tox protein, it was consequently fractionated according to a
protocol frequently used for antimicrobial peptide purification. Over the course of purification, the anti-Spod-11-tox
immunoreactivity was found to be dissociated from the antimicrobial activity. This indicates that Spod-11-tox is not
processed into bioactive defensins in response to a microbial challenge.
Conclusions/Significance: Altogether, our results show that X-tox proteins have not evolved as defensin reservoirs and
have lost the antimicrobial properties of the ancestral insect defensins. The lepidopteran X-tox protein family will provide a
valuable and tractable model to improve our knowledge on the molecular evolution of defensins, a class of innate immune
effectors largely distributed over the three eukaryotic kingdoms.
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Introduction
Innate immunity is the sole line of defense of invertebrates.
Their immune response relies on diverse humoral and cellular
activities taking place both at local and systemic levels. The
invertebrate immune response has been extensively studied in
insects and today it is in the insect model, Drosophila melanogaster,
that we have the most integrated understanding of this
physiological function. Indeed, biochemical, genetic and molecu-
lar biology approaches have led to the characterization of the
molecular mechanisms involved in (i) pathogen recognition, (ii)
signal transduction through extra- and intra-cellular signaling
pathways, and (iii) pathogen elimination through the production of
effectors molecules and cell activation (for review see [1,2]).
Completion of genomic sequences from members of the four
major insect orders and subsequent comparative analysis indicate
that the basic set of molecules defining the D. melanogaster immune
repertoire is conserved across Diptera, Coleoptera, Hymenoptera,
and Lepidoptera [3–6].
Albeit the immune system framework seems to be conserved
across insects, specific characteristics are observed in some insect
orders. Thus, hemolin is a bacteria-inducible pattern recognition
protein of the immunoglobulin superfamily, which is specific of the
Lepidoptera immune system [7,8,9]. Recently, we have also
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Lepidoptera, which encode the so-called X-tox proteins [10]. This
is a unique family of genes, whose deduced amino-acid sequence is
composed of a variable number (X) of cysteine-stabilized alpha
beta motifs (CS-ab). This motif is characteristic of invertebrate
defensins and scorpion toxins [11]. In the Spodoptera frugiperda
(Lepidoptera, Noctuoidea) Spod-11-tox protein, 11 cationic
domains with a CS-ab motif share the following consensus
sequence: C-x4-C-x3-C-x7-G-x-C-x3-K/R-C-x-C. Similarly, there
are six CS-ab motifs in Galleria mellonella (Lepidoptera, Pyraloidea)
[12] and five to six in Bombyx mori (Lepidoptera, Bombycoidea)
[13]. Phylogenetic analysis supports the hypothesis that X-tox
proteins, which are evolutionary derived from lepidopteran
defensins, represent a new family of proteins restricted to
Lepidoptera. In a previous study, S. frugiperda spod-11-tox gene
expression was shown to be rapidly induced upon experimental
infection, and unlike insect defensin genes, blood cells were
identified as the main site of spod-11-tox gene expression.
Puzzled by the combination of 11 variants of defensin-like
peptides in a single protein, we asked whether Spod-11-tox is a
reservoir of defensins with antimicrobial activities. To answer that
question, we performed a protein study in which we monitored the
outcome of the Spod-11-tox protein in terms of tissue localization
and putative processing, in insects exposed to a microbial
challenge. We first raised polyclonal antibodies directed against
rSpod-11-tox and showed that during a bacterial infection, Spod-
11-tox rapidly accumulates within secretory granules of the two
main classes of hemocytes (granulocytes and plasmatocytes) in a
membrane-associated form. Spod-11-tox expression was found to
be independent of the phagocytic activity of hemocytes and the
protein never co-localized with phagocytosed microorganisms,
showing that the Spod-11-tox protein is not involved in
intracellular pathogen killing and probably not in non-self-
recognition neither. Because Spod-11-tox was found to be rapidly
secreted into the hemolymph following challenge, it may play a
role in the systemic immune response. In the insect plasma (cell-
free hemolymph), the anti-Spod-11-tox immunoreactivity was
dissociated from the antimicrobial activities, as determined
following purification in conditions known to preserve antimicro-
bial properties. Altogether, our results show that although Spod-
11-tox is organized in a cluster of 11 defensin motifs, this large
protein is not a reservoir of what is referred as antimicrobial
defensins.
Materials and Methods
Insects and Immune Challenge
S. frugiperda was reared on artificial diet at 23uC with a
photoperiod of 12 h. Sixth-instar larvae were used for the
expression studies. Experimental infections were performed by
an injection of 20 mL of PBS-washed microorganisms per larvae
(numbers of microorganisms injected are indicate in figure
captions). Two bacterial strains were used, namely Escherichia coli
CIP7624 (Gram-negative) and Micrococcus luteus CIP5345 (Gram-
positive), as well as the yeast strain Pichia pastoris (GS115 from
Invirogen
TM).
Raising Specific Antibodies to Spod-11-tox
A New-Zealand rabbit was first subcutaneously injected with an
emulsion of 80 mg of the purified rSpod-11-tox solubilized in
complete Freund’s adjuvant (CFA; Gibco-BRL), and then
intramuscularly boosted twice with 80 mg of rSpod-11-tox
solubilized in incomplete Freund’s adjuvant (IFA; Gibco-BRL).
Finally, rabbit was intramuscularly boosted four times at 1-month
intervals with 80 mg of rSpod-11-tox solubilized in IFA. The rabbit
was killed and the whole serum was collected. Polyclonal
antibodies to rSpod-11-tox were affinity-purified through a
column of rSpod-11-tox coupled to NHS-activated HP matrix
(GE Healthcare), according to the protocol recommended by the
manufacturer. All experiments using rabbits were conducted in the
DSV-accredited animal facility at the Molecular Biochemistry
Research Center (agreement number: C3417204) and handled in
accordance with institutional guidelines. All experiments using
rabbits were approved by the Ethics Committee of the University
of Montpellier 2.
Protein extracts and Western blotting
Hemolymph was collected, from a cut abdominal proleg, into
ice-cold anti-coagulant buffer (69 mM KCl, 27 mM NaCl, 2 mM
NaHCO3, 100 mM D-glucose, 30 mM tripotassium citrate,
26 mM citric acid, 10 mM Na2–EDTA, pH 4.6, 420 mOsm).
Hemocytes and plasma were separated by centrifugation at 6006g
during 30 seconds at 4uC. Hemocytes were washed once in ice-
cold PBS and once in buffer A (20 mM Tris-HCl, pH 7.5, 3 mM
MgCl2, 1 mM EDTA, containing the complete protease inhibitor
cocktail from Roche at a concentration of one tablet for 10 mL).
Hemocyte lysis was performed using buffer A in the presence of
0.1% Triton X-100. The membrane and cytosolic fractions were
prepared in buffer A using a Dounce homogenizer and
centrifugation at 14,0006g for 30 min at 4uC. The cytosolic
fraction was removed, and the crude membrane fraction was
washed once in buffer A and dissolved in the same buffer. The
protein content was measured by the Bradford assay from Bio-Rad
using Bovine Serum Albumin (BSA) as standard. Proteins were
separated by SDS-PAGE under reducing conditions, and
transferred onto membranes (Immun-Blot
TM PVDF 0,22 mm
membrane from Bio-Rad). Membranes were probed with
polyclonal anti-Spod-11-tox antibodies diluted at 120 ng/mL in
PBS; 0.05% Tween-20; 1% BSA. A horseradish peroxidase-
coupled anti-rabbit IgG (GE Healthcare) was used at a 1:5,000
dilution for detection by chemiluminescence (ECL Western
blotting detection, GE Healthcare) and was then exposed to
Hyperfilm-ECL (GE Healthcare).
Immunolabelling and Microscopy
Hemocyte monolayers were prepared as previously described
[14]. Briefly, the collected hemocytes were resuspended in 1 mL of
PBS. Hemocyte suspensions were layered on 12 mm diameter
heat-sterilized glass coverslips in 24 well plates, and cells were
allowed to adhere on glass for 10 min at room temperature. Cells
were fixed in 3.7% formaldehyde, 0.25% glutaraldehyde in PBS
for 20 min, washed with PBS, incubated in 50 mM NH4Cl for
10 min and washed with PBS plus 0.2% BSA. Cells were
permeabilized in 0.4% Triton X-100 in PBS for 4 min, rinsed in
PBS and incubated with rabbit anti-Spod-11-tox antibody
(1.2 mg/mL) at room temperature for 20 min. After washing in
PBS, samples were incubated at room temperature for 20 min
with TRITC (Tetra methyl Rhodamine Iso Thio Cyanate)-
conjugated goat anti-rabbit secondary antibody (Sigma T6778;
dilution 1:400) and observed with a Leica TCS 4D Laser Confocal
Microscope. Processing of cells in the absence of primary antibody
served as a negative control. DNA was visualized with DAPI (Di
Aminido Phenyl Indol). The constitutive green fluorescent protein
(GFP)-labelled E. coli XL1 (DE3) was a generous gift from A.
Givaudan [15].
For immunogold labelling in TEM, hemocytes or insect tissues
were fixed in 3.7% formaldehyde plus 0.25% glutaraldehyde in
PBS for 2 h, dehydrated in alcohol and embedded in Unicryl
TM
Spod11tox Isn’t Cleaved in AMP
PLoS ONE | www.plosone.org 2 August 2009 | Volume 4 | Issue 8 | e6795resin according to the manufacturer. Ultrathin sections were
incubated in rabbit anti-Spod-11-tox antibody at room tempera-
ture for 2 h, rinsed and incubated in immunogold labelled protein
A, then finally counterstained with 2.5% uranyl acetate for 5 min.
Plasma Purification Procedure
Extraction and prepurification by solid-phase extraction
(SPE). Plasma from PBS-challenged (5.2 mL) or live bacteria-
challenged (28 mL) larvae, was acidified to pH 2 with 1 M HCl.
The acidic extraction was performed over night under gentle
shaking at 4uC. After centrifugation (16,000 g for 30 min at 4uC),
the supernatant was prepurified by SPE on Sep-Pak C18 cartridges
(Waters) equilibrated with acidified water (0.05% trifluoroacetic
acid, TFA). Elutions were performed with 10, 40, and 80%
acetonitrile in acidified water. All fractions were freeze-dried in a
vacuum centrifuge (Speed-Vac, Cryo Rivoire) and subsequently
reconstituted with MilliQ water at 1/20 of the initial hemolymph
volume.
HPLC purification. STEP 1 - The 40% Sep-Pak fractions were
subjected to reversed-phase chromatography on an UP5NEC25QS
column (Interchim) equilibrated in acidified water. Separation of the
40% Sep-Pak fractions was performed with a linear gradient of 0-60%
acetonitrile in acidified water over 80 min at a flow rate of 1 mL/min.
STEP 2 - Different gradients were used for this second
purification step. Immunoreactive fractions were purified on the
same reversed-phase column as in STEP 1 at a controlled
temperature of 35uC. Linear biphasic gradients were used
according to the following calculation, for a fraction eluted with
X% acteonitrile, the gradient was composed of 0-(X-6)%
acetonitrile in acidified water over 5 min, and of (X26)%-
(X+9)% over 45 min at a flow rate of 1 mL/min.
STEP 3 – When needed, the fractions of interest were subjected
to a final purification step on a narrow-bore reversed-phase
column (Xbridge BEH130, Waters Associates) at 40uC at a flow
rate of 0.25 mL/min using the biphasic gradients described in
STEP 2.
All HPLC purifications were performed on a Waters HPLC
system (Waters 600 pump) equipped with a photodiode array
(Waters 996 PDA). Column effluent was monitored by its UV
absorption at 225 nm. Fractions corresponding to absorbance
peaks were hand collected in polypropylene tubes (Microsorb
75 mm612 mm, Nunc immunotubes), concentrated under vacu-
um (Savant) and reconstituted in MilliQ water (Millipore
TM)
before antimicrobial activity and immunoreactivity testing.
Antimicrobial Assays
Antimicrobial activity was assayed against two bacteria,
Micrococcus luteus (CIP5345), and Escherichia coli (SBS 363 or
CIP7624), and against the filamentous fungus Fusarium oxysporum
(generous gift from A. Vey, INRA Saint Christol-le `s-Ale `s) based on
the liquid growth inhibition assay described by Hetru and Bulet
[16]. Poor Broth (PB: 1% bacto-Tryptone, 0.5% NaCl w/v,
pH 7.5), and K Potato Dextrose Broth (Difco) were used for
bacterial and fungal growth, respectively. Growth of bacteria was
monitored spectrophotometrically at 600 nm on a multifunctional
microplate reader (Tecan infinite 200) while fungal growth was
evaluated after 24 and 48 hours at 30uC by optical microscopy
and measurement of the culture absorbance at 595 nm.
Dot-blot ELISA assay
Anti-Spod-11-tox immunoreactivity of HPLC fractions was
measured by spotting 1 mL of each fraction on membranes
(Immun-Blot
TM PVDF 0,22 mm membrane from Bio-Rad).
Membranes were probed with anti Spod-11-tox antibodies (as
described in ‘‘Protein extracts and Western blotting’’).
Results
Expression pattern of Spod-11-tox during immune
response
To investigate the outcome of the Spod-11-tox protein during
the immune response we produced antibodies directed against
recombinant protein (rSpod-11-tox). These antibodies were used
in western blot experiments to monitor the expression of the Spod-
11-tox protein in larvae subjected to PBS or E. coli injections. In
agreement with our previous gene expression data [10], Spod-11-
tox was mainly produced by hemocytes of bacteria-challenged
insects (Figure 1A). Two immunoreactive bands were detected by
anti-Spod-11-tox antibodies that likely correspond to the products
of the two transcripts previously revealed by Northern Blot
analysis [10].
In order to define more precisely the cellular location of Spod-
11-tox, we prepared membrane and cytosolic fractions from S.
frugiperda larvae hemocytes. Western blots showed that Spod-11-
tox is mainly recovered into the membrane fraction suggesting that
the protein is associated to cell membranes or to intracellular
organelles (Figure 1B).
Altogether, these results indicate that in response to a bacterial
infection, Spod-11-tox rapidly accumulates into hemocytes, either
bound to cell membranes or stored in intracellular organelles.
Moreover, Spod-11-tox was also observed in plasma. Since no
trace of a-tubulin was found in the plasma, the presence of Spod-
11-tox in plasma is due to secretion of the protein rather than cell
lysis.
Hemocyte cell types involved in Spod-11-tox production
To define the hemocyte cell types involved in Spod-11-tox
production, we performed immunofluorescence on hemocytes
Figure 1. Expression pattern of Spod-11-tox during the
immune response. A) Spod-11-tox is mainly expressed in hemocytes
upon immune challenge. Western blot analyses were performed with
protein extracts from plasma (Pl), fat body (FB) and hemocytes (He) of S.
frugiperda larvae 24 h post injection of PBS (P) or E. coli (Ec,1 0
5
bacteria/larvae). Proteins were loaded (20 mg/lane) on a 10% SDS-PAGE.
The blot was successively probed with both a polyclonal anti-Spod-11-
tox antibody (Spod-11-tox, upper panel) and an anti-a-tubulin antibody
(a-Tub, lower panel). The absence of a signal with a-tubulin antibody
indicates that the plasma preparations are not contaminated by cells. B)
Sub cellular location of Spod-11-tox. Membrane (memb.) and cytosolic
(cyto.) fractions were prepared with hemocytes withdrawn from S.
frugiperda larvae (challenged as described in A) and separated on a 10%
SDS-PAGE. Protein separation and western blot were performed as in A.
doi:10.1371/journal.pone.0006795.g001
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PLoS ONE | www.plosone.org 3 August 2009 | Volume 4 | Issue 8 | e6795Figure 2. Hemocyte cell types involved in Spod-11-tox production. A) Immunofluorescence staining of Spod-11-tox in hemocytes
withdrawn from S. frugiperda larvae 6 h post injection with PBS (a, b, c) or E. coli (10
5 bacteria/larvae) (d, e, f). Cells were DAPI stained (a, d) and
immunolabelled with rabbit anti-Spod-11-tox revealed by TRITC-conjugate anti-rabbit (b, e). Overlays of DAPI and TRITC were shown in c and f.
Yellow arrows and white arrowheads indicate plasmatocytes and granulocytes respectively. Bars=20 mm. B) Spod-11-tox appeared mainly
aggregated within the cytoplasm in a manner evocative of granule-like vesicles. Higher magnification of a plasmatocyte withdrawn from S. frugiperda
larvae 6 h post injection of E. coli (10
5 bacteria/larvae). Bars=10 mm. C) Relative percentage of Spod-11-tox immunolabelled circulating hemocytes.
Same experiment as in A except that hemocytes were withdrawn at the indicated times. Data are presented as mean6SD of at least three
independent experiments (a minimum of 2,000 hemocytes/condition were counted). D) Intracellular location of Spod-11-tox. Same experiment as in
B except that hemocytes were withdrawn 3 h post challenge and were (Per.) or were not (N Per.) permeabilized before immunolabelling.
doi:10.1371/journal.pone.0006795.g002
Spod11tox Isn’t Cleaved in AMP
PLoS ONE | www.plosone.org 4 August 2009 | Volume 4 | Issue 8 | e6795Figure 3. Subcellular localization of Spod-11-tox. A) Confocal microscopy of phagocytosed E. coli. Immunofluorescence staining of Spod-11-
tox containing hemocytes withdrawn from S. frugiperda larvae 3 h post injection of GFP-expressing E. coli (10
7 bacteria/larvae). Cells were
immunolabelled with rabbit anti-Spod-11-tox revealed by TRITC-conjugate anti-rabbit. Bars=5 mm. B) Immunoelectron microscopy of granulocytes
withdrawn from S. frugiperda larvae 3 h post injection of Pichia pastoris (10
6 yeast/larvae). Note the presence of heterogeneous bodies looking like
secondary lysosomes (b), phagocytosed P. pastoris (c) and structured granules (e). Immunogold labelling using 10 nm colloidal gold-conjugated
Protein A. Bars=0.5 mm.
doi:10.1371/journal.pone.0006795.g003
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PBS-treated larvae, only few hemocytes were immunoreactive to
anti-Spod-11-tox antibodies whereas in E. coli-treated larvae, most
hemocytes were immunolabelled (Figure 2A, b and e). Plasmato-
cytes and granulocytes, which represent approximately 85–95% of
all hemocytes in last instars larvae [17], are easily identified
according to their nuclei size (Figure 2A, d; plasmatocytes, yellow
arrow; granulocytes, white arrowhead). Both cell types were
recognized by the anti-Spod-11-tox antibodies (Figure 2A, e and f).
At higher magnification, Spod-11-tox appeared mainly aggregated
within the cytoplasm in a manner evocative of granule-like vesicles
(Figure 2B).
Interestingly, 80% of the cells were labelled as soon as 3 h after
septic injury, while the percentage of Spod-11-tox-labelled
hemocytes remained low in PBS-treated and not significantly
different from unchallenged larvae (Figure 2C). The total lack of
labelling of non-permeabilized hemocytes (Figure 2D) demon-
strated the intracellular location of the protein.
Altogether, these results demonstrate that, in vivo, a bacterial-
challenge rapidly induces Spod-11-tox synthesis and accumulation
in granulocytes and plasmatocytes, the two main classes of
hemocytes.
Subcellular localization of Spod-11-tox during
phagocytosis
The intracellular location of Spod-11-tox in granule-like vesicles
raised the question of its involvement in intracellular bacterial
killing. We therefore examined whether Spod-11-tox-expressing
hemocytes were preferentially involved in bacterial phagocytosis
using a GFP-expressing E. coli strain. Phagocytosed bacteria were
observed in both Spod-11-tox-labelled and unlabelled hemocytes.
In addition, immunolabelled cells free of phagocytosed bacteria
were also observed, suggesting that Spod-11-tox expression was
not associated to phagocytosis (data not shown). Moreover,
confocal microscopy showed that bacteria are found in a cell
compartment devoid of Spod-11-tox (Figure 3A). Similar results
were obtained when hemocytes withdrawn from S. frugiperda larvae
3 h after an injection of Pichia pastoris were immunogold-labelled
with anti-Spod-11-tox antibodies. Indeed, gold particles revealing
the presence of Spod-11-tox were not present in yeast-containing
phagocytic vacuoles (Figure 3B, a and c). Moreover, immunogold
electron microscopy further localized Spod-11-tox in hemocyte
heterogeneous bodies (Figure 3B b) and in structured granules
(Figure 3B, d and e). The later organelles are typical inclusions of
granular cells in most insect orders [18] and are released into the
plasma upon infection [19].
These results showed that Spod-11-tox expression is indepen-
dent of hemocyte phagocytosis and that the protein does not co-
localize with phagocytosed microorganisms suggesting that the
protein is not involved in intracellular pathogen killing. In
addition, the absence of co-localization suggests that Spod-11-
tox is not involved in non-self-recognition. This is supported by
immunolabelling experiments showing that, in vitro, rSpod-11-tox
does not directly interact with E. coli or P. pastoris (data not shown).
Spod-11-tox is secreted into the hemolymph but not
processed into bioactive defensins
The intracellular localization of Spod-11-tox suggested a
secretion of Spod-11-tox proteins into the insect plasma. We
therefore performed a time-course analysis of Spod-11-tox
expression and secretion. Insect hemolymph was collected at
different time intervals post-microbial challenge and both plasma
and hemocytes were subjected to western-blot analysis for Spod-
11-tox detection. Spod-11-tox was almost undetectable in protein
extracts of hemocytes from unchallenged larvae, the protein
massively accumulated in hemocytes until 12 h post-infection and
then decreased (Figure 4A). A similar profile was obtained with
plasma except that Spod-11-tox detection was delayed compared
to hemocytes extracts (Figure 4B).
The Spod-11-tox protein that we found here to be secreted into
the insect hemolymph upon microbial challenge was also found to
be subjected to major processing. Indeed, a succession of bands
(around 10) spreading out over the 25–150 kDa range was
Figure 4. Time course analysis of Spod-11-tox expression in
challenged S. frugiperda larvae (E. coli 10
5 bacteria/larvae). A)
Western blot analyses performed with protein extracts from hemocytes
(from 6 to 72 hours post infection). B) Comparison of Spod-11-tox
content in hemocytes and plasma early post infection. Proteins were
loaded (10 mg/lane) on a Tris-Tricine 10–20% gradient gel. The western
blot was realized as in figure 1. Numbers on the right sides of the blots
indicate the molecular weight (kDa) estimated using Precision Plus
Protein
TM Standards from Bio-Rad. Un; unchallenged.
doi:10.1371/journal.pone.0006795.g004
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post infection. This indicates that Spod-11-tox, with a calculated
molecular mass at 75.9 kDa, is naturally processed in smaller
forms. In the Tris-Tricine 10–20% gradient gel used, no
immunoreactive band was observed below 10 kDa, i.e. the
molecular mass range where defensin-like domains may be
expected, neither in hemocytes nor in plasma. To ensure that
putative low molecular mass molecules can be recognized,
recombinant Spod-11-tox was cleaved by the V8 protease and
analyzed by western blot. Under these conditions, anti-Spod-11-
tox antibodies were able to detect peptides as small as 3 kDa,
which nonetheless were devoid of antimicrobial activity (data not
shown). These results strongly suggest that the cleavage or
maturation of Spod-11-tox observed in hemocytes during the first
24 hours of infection does not generate defensin-like subunits.
To determine if the Spod-11-tox secreted into the insect
hemolymph over the immune response is matured into defensin
peptides, S. frugiperda plasma was fractionated according to a
protocol widely used to isolate and characterize antimicrobial
peptide [20]. Five hundred sixth instar larvae were challenged by
injection of bacteria, and the hemolymph (28 mL final volume)
was collected after 8 h. In a parallel experiment, hemolymph from
PBS-challenged larvae was treated under the same conditions. The
plasma of insects was then acidified and fractionated by solid phase
extraction on reversed phase Sep-Pak cartridges (Figure 5A).
While anti-Spod-11-tox immunoreactivity was specifically found
in the Sep-Pak fractions obtained from bacteria-challenged larvae
(Figure 5B), similar profiles of antimicrobial activity were found for
PBS- and bacteria-challenged larvae (Figure 5C). More specifical-
ly, the 10% Sep-Pak fraction from bacteria-challenged larvae,
which contained most of the anti-Spod-11-tox immunoreactivity
(Figure 5B), had no activity against the micro-organism tested. In
fact, most of the antimicrobial activity was found in the 40% Sep-
Pack fraction (Figure 5C). Conversely, no immunoreactivity
against Spod-11-tox was found in the 40% fraction from PBS-
injected larvae (Figure 5B), whereas this fraction was clearly active
against E. coli (Figure 5C).
Further purification of the plasma collected from bacteria-
challenged larvae revealed the absence of Spod-11-tox-derived
defensins in the 40% Sep-Pak fraction, which is reported to contain,
in the Heliothis virescens model at least the heliomicin, a lepidopteran
defensin [20]. Indeed,no anti-Spod-11-toximmunoreactive peptide
was observed below 10 kDa on SDS-PAGE of the Sep-Pak-
fractionated plasma (Figure 5B), while defensin molecular masses
are expected at ,4 kDa. In addition, when separated by reversed-
phase HPLC using a protocol adapted for defensin isolation, the
40% Sep-Pak-fractionated plasma from bacteria-challenged larvae
displayed dissociated antimicrobial activity and anti-Spod-11-tox
immunoreactivity. This was demonstrated by subjecting all HPLC-
collected fractions to antimicrobial assays against E. coli (Gram-
negative bacterium), M. luteus (Gram-positive bacterium), and
Fusarium oxysporum (filamentous fungus) on the one hand, and to
an anti-Spod-11-tox dot-blot ELISA on the other hand. Thus, after
a first purification step, some immunoreactive fractions (eluted
around 52% acetonitrile) already lacked antimicrobial activity
(Figure 6, inset a). Fractions which displayed both antimicrobial
activity and immunoreactivity (eluted around 35% acetonitrile,
Figure 6), where further purified with the objective of identifying
Figure 5. Purification procedure and properties of S. frugiperda hemolymph. A) Schematic representation of the protocol used for the
purification of the insect hemolymph. Proteins were eluted from the Sep-Pack C18 cartridge with 10, 40, and 80% ace ´tonitrile prepared in acidified
water (TFA 0.05%), lyophilizated and reconstituted with MilliQ water. B) Western blot analysis of Spod-11-tox content in the elution fractions of Sep-
Pack C18 cartridge. Protein extracts were loaded (15 mg/lane) on a Tris-Tricine 16.5% gel and blotted on a PVDF membrane. The blot was Coomassie
stained (upper panel) and probed with polyclonal anti-Spod-11-tox antibody (lower panel). Numbers on the right sides of the blots indicate the
molecular weight (kDa) estimated using Precision Plus Protein
TM Standards from Bio-Rad. C) The eluted Sep-Pack fractions were tested for their
antimicrobial activities by liquid growth inhibition assay against E. coli (CIP7624). Results are representative of three independents experiments.
doi:10.1371/journal.pone.0006795.g005
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between the immunoreactivity and the antimicrobial activity was
observed over the course of the purification, as shown for two of
them in Figure 6 (inset b and c). Altogether, our data strongly
suggest that Spod-11-tox is not processed into defensins, which in
Lepidoptera, are reported to be antifungal.
Discussion
The data presented in this study of the Spod-11-tox protein
showed that this acute phase protein is produced upon microbial
infection by granulocytes and plasmatocytes (the two main classes
of circulating hemocytes) and processed into lower molecular
masse components before being rapidly secreted into the plasma
where it participates to a systemic response rather than being
involved in intracellular pathogen killing.
In response to infection, Spod-11-tox was found to accumulate in
heterogeneous bodies that are present in both plasmatocytes and
granulocytes and in structured granules, (granulocyte-specific
organelles) involved the protein secretion into the plasma. This
later localization of Spod-11-tox, in addition to the presence of a
signal peptide on the amino-terminal part of the protein, supports
the involvement of Spod-11-tox in the systemic immune response.
Indeed, Spod-11-tox expression in hemocytes is independent of
phagocytosis and Spod-11-tox does not co-localize with phagocy-
tosed microorganisms.Thisisincontrastwithmammaliandefensins
which are stored in leukocyte granules that fuse to phagocytic
vacuoles and deliver defensins onto the target microorganism [21].
Storage of immune proteins including antimicrobial peptides
(AMPs) in hemocyte granules has already been reported in
invertebrates. For example, AMPs are constitutively present in
hemocytes of the mussel Mytilus galloprovincialis [22], the shrimp
Penaeus vannamei [23], the horseshoe crab Tachypleus tridentatus [24],
and the termite Pseudacanthotermes spiniger [25]. However, in those
organisms, AMPs are constitutively present and not induced upon a
microbial challenge as observed for Spod-11-tox.
Intense processing of Spod-11-tox was observed within
hemocytes of challenged insects, which is then released into the
blood stream. However, we showed here that the insect plasma,
which is rich in antimicrobials, is devoided of bioactive Spod-11-
Figure 6. Discrimination between antimicrobial properties and anti-Spod-11-tox immunoreactivity of the fractionated S. frugiperda
hemolymph. The 40% Sep-Pack fraction from the extraction of immunized S. frugiperda plasma was subjected to reversed-phase HPLC on an
Interchim UPNEC25QS column using a 0–60% linear gradient (dashed line) of acidified acetonitrile over 80 min. Antimicrobial activity against E. coli
SBS363 (black rectangles) M. luteus (grey rectangles) and F. oxysporum (white rectangles) was measured by liquid growth inhibition assays. Anti-Spod-
11-tox immunoreactivity (hatched rectangles) was measured by dot-blot ELISA. Insets show the dissociation between immunoreactive and
antimicrobial fractions over the course of the purification. a: at the first purification step; b: at the second purification step (same column with a 0-27-
42% biphasic linear gradient of acidified acetonitrile over 5 and 40 min); c: at the third purification step (Xbridge BEH300 narrowbore column with a
0-23-43% biphasic gradient of acidified acetonitrile over 5 and 80 min). Absorbance (Abs) was monitored at 225 nm.
doi:10.1371/journal.pone.0006795.g006
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cleavage of rSpod-11-tox with V8 protease failed to generate
peptides with antimicrobial activity. The lack of organized
processing as found in other AMP precursors [26,27] is also
supported by previous sequence analysis of Spod-11-tox, which
showed that the spacer region bridging the Spod-11-tox CS-ab
motifs are not conserved and lack potential conserved cleavage
sites that could be recognized by a specific processing enzyme [10].
Altogether, the data obtained in this work indicate that Spod-11-
tox, whose structure is evocative of a defensin rosary, is not
processed into bioactive defensin peptides. This rules out the
hypothesis of Spod-11-tox being a precursor for defensins, whose
sequence diversity may result in complementary and/or synergistic
activities beneficial for insect defense. This conclusion is corrobo-
rated by studies conducted on two other lepidopteran species. In
Heliothis virescens, an EST program performed on immune-
stimulated hemocytes lead to the characterization of an x-tox gene
[28]. The amino acid sequence deduced from this gene revealed
that it contains three CS-ab motifs (GenBank accession number
ACI02333).Interestingly, none of them correspond to antimicrobial
peptides, includingheliomicin the H. virescens defensin, purified from
this insect in our previous systematic analysis of H. virescens plasma
[20]. In G. mellonella, three defensins were purified by biochemical
approaches similar to the one used in this work [29,30] and none of
them derived from the proteolytic cleavage of Gall-6-tox (the X-tox
protein characterized in G. mellonella [12]). This suggests that in H.
virescensand in G. mellonella, like in S. frugiperda, X-tox proteins arenot
processed into individual bioactive defensins.
Because the antimicrobial activity of insect plasma was found
not to be associated to the presence of Spod-11-tox-derived
defensins nor to the presence of larger Spod-11-tox processing
products, we believe that overall, Spod-11-tox is not directly
involved in the microorganism killing. Expression studies revealed
that in S. frugiperda three defensin genes (spodoptericin, Sf-gallerimycin
and Sf-cobatoxin) are up regulated, to a variable degree, upon
challenge [31]. Thus, during immune response, S. frugiperda
produces simultaneously defensins and Spod-11-tox protein.
Similar results were obtained for G. mellonella [12,30]. Altogether,
these observations lead us to hypothesize that X-tox proteins
evolved to a distinct function. This function is most likely unrelated
to pathogen recognition and opsonisation since Spod-11-tox is not
expressed at hemocyte surface, does not interact with pathogens,
and does not co-localize with phagocytosed microorganisms.
In conclusion, we showed here that, through evolution, Spod-
11-tox and probably all X-tox proteins, have lost the function of
ancestral insect defensins. To gain more insight into the immune
function(s) of X-tox proteins, other experimental approaches, such
as gene knock down will be needed. What driving force allowed
the evolution of defensins in X-tox proteins in Lepidoptera solely
remains to be determined. We believe that through the X-tox
protein family, Lepidoptera will provide a valuable and tractable
model to improve our knowledge on the molecular evolution of
defensins, a class of innate immunity effectors largely distributed
over the three eukaryotic kingdoms.
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